Nature Biotechnology涵盖了整个生物技术领域，以吸引众多读者。该刊所有决定均由全职编辑人员提供。 
期刊收录研究方向：基因工程（控制基因表达策略、基因控制基因策略、基因遏制策略），成规模方法（基因功能分析技术、基因结构/组织分析技术、基因组学或化学遗传学、药物基因组学、计算分析），蛋白组组学（分析/识别蛋白质结构/功能技术，结构基因组学，计算分析），代谢组学（代谢产物分析、分析技术，计算分析），计算生物学（生物信息学、算法、数据反卷积，建模与系统生物学），分子工程（蛋白质、抗体、酶、药物的合理途径，分子进化，分子育种方法），代谢工程（物种遗传操控以修饰或允许生产商业或治疗相关化合物，计算分析），新型表达系统（哺乳动物细胞、昆虫细胞、细菌、菌类、植物细胞），基因、药物或细胞的传递（定位策略、病毒和非病毒载体策略），成像（报道分子，用于观察整个动物、细胞或单个分子的成像方法/技术，计算分析），核酸疗法（基因治疗，抗转录疗法，RNAi，DNA酶和核糖酶），纳米生物技术（用于药物传递或治疗的纳米材料，用于工业生物技术的纳米材料，纳米传感器，用于分子和细胞成像的纳米系统），疫苗与应用免疫学（抗体工程、T细胞疗法、先天免疫疗法、抗原递送载体和途径、核算疫苗、计算分析），再生医学（干细胞、组织工程、治疗性克隆，异种移植，生物材料），生物传感器（检测生物分子的方法，生物系统在检测分析物中的用途），化验系统（多路复用和提高产量的方法，基因、蛋白质和药物的选择与筛选策略，微流控），生物材料（生物工程材料，分子印迹，仿生学，纳米技术），农业生物技术和转基因植物（作物改良，保健品，林业生物技术，植物疫苗，植物生物反应器，基因遏制策略），嫁接（转基因动物，生殖克隆，生物制药和酶生产，转基因靶向和表达策略），环境（生物修复，生物采矿，植物修复，监控）

Article
Letter
Brief Communication
Resource, Analysis
Correspondence
Matters Arising
News and Views
Book Review
Review
Commentary
Perspective
Feature
Patent Article
Careers
Recruitment
Primer

Chief Editor: Andrew Marshall (New York)
Andy obtained his PhD and postdoctoral experience in molecular biology and microbiology at King's College London. Before joining Nature Biotechnology in 1996, he was Editor of Current Opinion in Biotechnology for four years. He has written numerous articles and editorials on science and technology for the popular media, including The Economist, and for trade publications. As well as frequently speaking on biotechnology issues at international meetings, he regularly organizes conferences and symposia for Nature Research in the biotechnology area.
a.marshall@us.nature.com
Deputy Editor: Kathy Aschheim (San Francisco)
Kathy did her graduate work in the department of Molecular Biophysics and Biochemistry at Yale University in the laboratory of Thomas Steitz, where she studied DNA and RNA polymerase complexes by X-ray crystallography. She also worked in the laboratory of Steven Smith on structural studies of membrane proteins using solid-state NMR. Before that, Kathy received a PhD in literature from Yale and taught at Northwestern University. She joined the journal in 2001.
k.aschheim@us.nature.com
Senior Editor: Laura DeFrancesco (Pasadena)
Laura received her PhD at the University of California, San Diego in cell biology and did postdoctoral work on mitochondrial nucleic acids at California Institute of Technology. After doing research for 10 years at the City of Hope National Cancer Center and the University of California, Los Angeles on various topics in animal and cell science, she became the founding editor of the LabConsumer section of The Scientist. Following that, she was managing editor of the web-based life science portal BioResearch Online, and later went on to write for several publications, including Nature Medicine, Analytical Chemistry, and BioIT World. She joined the journal in 2003 and is responsible for Features and Reviews.
l.defrancesco@us.nature.com
Senior Editor: Michael Francisco (New York)
Michael obtained bachelor's degrees in biotechnology and art history from Rutgers University, with concentrations in industrial microbiology and ancient Greek sculpture. He is responsible for Nature Biotechnology's Patents and Careers sections, and also manages social media for the journal. He joined Nature Biotechnology in 1996.
m.francisco@us.nature.com
Senior Editor: Susan Jones (London)
Susan obtained a PhD at the University of Warwick, UK, where she studied quorum sensing in a plant pathogenic bacterium. She did her postdoctoral work at Imperial College London, UK, investigating transcriptional mechanisms underlying stress responses in bacteria. She left the lab in 2003 to join Nature Reviews Microbiology, becoming Chief Editor in 2008, then joined the PLoS Medicine team and became Senior Research Editor in 2011. Susan joined Nature Biotechnology in 2012.
s.jones@nature.com
Senior Editor: Markus Elsner (Heidelberg)
Markus did his graduate work at EMBL in Heidelberg, Germany and the University of Gothenburg, Sweden, where he worked on characterizing protein dynamics in living cells. In his postdoctoral studies at the National Institutes of Health he investigated the mechanisms of lipid and protein sorting during membrane transport events. He joined the journal in 2008.
m.elsner@us.nature.com
Senior Editor: Irene Jarchum (New York)
Irene obtained her PhD at Albert Einstein College of Medicine in the Bronx, New York, where she studied the specificity of autoreactive T cells and mechanisms of central tolerance in type 1 diabetes. As a postdoctoral fellow at Memorial Sloan-Kettering Cancer Center, her research focused on mucosal immunity against the gut pathogen Clostridium difficile. She was an editor at Nature Communications before joining the Nature Biotechnology team in 2014.
irene.jarchum@us.nature.com
Senior Editor: Sarah Perry (London)
Sarah received her PhD from the University of Oxford, UK, where she focused on developing multi-locus model selection strategies for genome-wide association studies. Sarah's postdoctoral studies in Oxford involved the identification of genetic and epigenetic mechanisms underlying complex metabolic traits such as insulin resistance and diabetes. She began her editorial career at Nature Communications in June 2013 and joined Nature Biotechnology in 2015.
sarah.perry@nature.com
Business Editor: Brady Huggett (New York)
Brady received a Bachelor of Science degree in biology from Wake Forest University and a master's in journalism from the University of North Carolina at Chapel Hill. Prior to joining Nature Biotechnology as business editor in 2007, he was managing editor at the biotech daily news service BioWorld, and he has also worked as a staff writer for a university research magazine. He has written articles covering all aspects of biotech, and has participated in or moderated panel discussions both in the United States and abroad.
b.huggett@us.nature.com
Senior News Editor: Lisa Melton (London)
Lisa obtained her PhD at the University of Buenos Aires and did her postdoctoral work at the National Institutes for Medical Research in London, where she investigated thymic differentiation. She then took a science writer's position at the Wellcome Trust and later the Novartis Foundation, contributing to Nature, Scientific American, New Scientist and the Times among others. She joined Nature Biotechnology in 2008.
l.melton@nature.com
Editorial advisors: John Hodgson, Mark Kessel, Mark Ratner, Chris Scott